Literature DB >> 3731890

Pulmonary hypertension in chronic obstructive pulmonary disease. Multivariate analysis.

C A Keller, J W Shepard, D S Chun, P Vasquez, G F Dolan.   

Abstract

The severity of pulmonary hypertension was evaluated by right cardiac catheterization in 89 patients with stable chronic obstructive pulmonary disease, both at rest and during maximum treadmill exercise. Thirty-one patients were found to have pulmonary hypertension at rest, defined as a mean pulmonary arterial pressure of 20 mm Hg or more. Although the remaining 58 patients had normal mean pulmonary arterial pressure at rest, three developed pulmonary hypertension during exercise (mean pulmonary arterial pressure greater than or equal to 35 mm Hg). Multiple anthropometric, spirometric, radiographic, and gas-exchange variables were analyzed and correlated with the hemodynamic data to define their value in predicting mean pulmonary arterial pressure. While arterial oxygen pressure (PaO2) at maximum exercise was the variable most highly correlated with resting mean pulmonary arterial pressure (r = -0.67), stepwise multiple linear regression analysis indicated that measurement of the diameter of the right descending pulmonary artery and arterial carbon dioxide tension (PaCO2) also contributed to the prediction of mean pulmonary arterial pressure. Spirometric indices of airflow obstruction, hyperinflation, and the diffusing capacity of the lung for carbon monoxide correlated poorly with the severity of pulmonary hypertension and consequently were not useful predictors of mean pulmonary arterial pressure. The threshold criteria of a PaO2 less than 60 mm Hg or a PaCO2 more than 40 mm Hg were reasonably accurate for a diagnosis of pulmonary hypertension. These arterial blood gas criteria were superior to the spirometric and radiographic variables examined in predicting pulmonary hypertension prior to the development of clinically overt cor pulmonale.

Entities:  

Mesh:

Year:  1986        PMID: 3731890     DOI: 10.1378/chest.90.2.185

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.

Authors:  P Egermayer; G I Town; A J Peacock
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

2.  Functional assessment of the right ventricle in patients with bronchial asthma of various severity.

Authors:  Grzegorz Mincewicz; Grzegorz Siergiejko; Marek Piepiorka; Agnieszka Świdnicka-Siergiejko; Zenon Siergiejko; Grzegorz Krzykowski
Journal:  Postepy Dermatol Alergol       Date:  2021-03-10       Impact factor: 1.837

3.  Combined use of non-invasive techniques to predict pulmonary arterial pressure in chronic respiratory disease.

Authors:  J M Bishop; M Csukas
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

4.  Detection of pulmonary hypertension by Doppler echocardiography of the inferior vena cava in chronic airflow obstruction.

Authors:  J P Laaban; B Diebold; M Lafay; J Rochemaure; P Peronneau
Journal:  Thorax       Date:  1989-05       Impact factor: 9.139

5.  One-year prognosis and the role of brain natriuretic peptide levels in patients with chronic cor pulmonale.

Authors:  So Young Park; Chang Youl Lee; Changhwan Kim; Seung Hun Jang; Yong Bum Park; Sunghoon Park; Yong Il Hwang; Myung Goo Lee; Ki-Suck Jung; Dong-Gyu Kim
Journal:  J Korean Med Sci       Date:  2015-03-19       Impact factor: 2.153

Review 6.  Underrecognized comorbidities of chronic obstructive pulmonary disease.

Authors:  Joanna Miłkowska-Dymanowska; Adam J Białas; Anna Zalewska-Janowska; Paweł Górski; Wojciech J Piotrowski
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-15

Review 7.  Epidemiology and clinical impact of major comorbidities in patients with COPD.

Authors:  Miranda Caroline Smith; Jeremy P Wrobel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-27

Review 8.  The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease.

Authors:  Adam Jerzy Białas; Przemysław Sitarek; Joanna Miłkowska-Dymanowska; Wojciech Jerzy Piotrowski; Paweł Górski
Journal:  Oxid Med Cell Longev       Date:  2016-12-26       Impact factor: 6.543

Review 9.  Pulmonary hypertension and chronic cor pulmonale in COPD.

Authors:  Adil Shujaat; Ruth Minkin; Edward Eden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.